PMID- 19031029 OWN - NLM STAT- MEDLINE DCOM- 20090219 LR - 20131121 IS - 0171-2004 (Print) IS - 0171-2004 (Linking) IP - 188 DP - 2009 TI - Handbook of experimental pharmacology "dendritic cells": the use of dexamethasone in the induction of tolerogenic DCs. PG - 233-49 LID - 10.1007/978-3-540-71029-5_11 [doi] AB - Dendritic cells (DCs) have a central role in immune regulation, ranging from tolerance induction to the induction of specific immune responses. DCs serve as an essential link between innate and adaptive immunity. This broad range of powerful immune stimulatory as well as regulatory functions has made DCs as targets for vaccine development strategies. One approach to promote the tolerogenicity of DCs is to suppress their maturation by pharmacological agents, including glucocorticoids (GCs). In the present chapter we will review GCs used in vitro with cultured DCs, applied in vivo, or used to generate tolerogenic DCs for cellular therapy. FAU - van Kooten, Cees AU - van Kooten C AD - Department of Nephrology, Leiden University Medical Center, C3P, Albinusdreef 2, P.O. Box 9600, Leiden, NL-2300RC, The Netherlands. C.van_Kooten@lumc.nl FAU - Stax, Annelein S AU - Stax AS FAU - Woltman, Andrea M AU - Woltman AM FAU - Gelderman, Kyra A AU - Gelderman KA LA - eng PT - Journal Article PT - Review PL - Germany TA - Handb Exp Pharmacol JT - Handbook of experimental pharmacology JID - 7902231 RN - 0 (Cytokines) RN - 0 (Immunosuppressive Agents) RN - 7S5I7G3JQL (Dexamethasone) SB - IM MH - Animals MH - Antigen Presentation/drug effects MH - Apoptosis/drug effects MH - Autoimmunity/drug effects MH - Cell Shape/drug effects MH - Cytokines/metabolism MH - Dendritic Cells/*drug effects/immunology/transplantation MH - Dexamethasone/*pharmacology MH - Graft Rejection/immunology/*prevention & control MH - Humans MH - Immune Tolerance/*drug effects/genetics MH - Immunosuppressive Agents/*pharmacology MH - Immunotherapy, Adoptive MH - Inflammation/immunology/*prevention & control MH - Phenotype MH - Signal Transduction/drug effects MH - T-Lymphocytes/drug effects/immunology RF - 90 EDAT- 2008/11/26 09:00 MHDA- 2009/02/20 09:00 CRDT- 2008/11/26 09:00 PHST- 2008/11/26 09:00 [pubmed] PHST- 2009/02/20 09:00 [medline] PHST- 2008/11/26 09:00 [entrez] AID - 10.1007/978-3-540-71029-5_11 [doi] PST - ppublish SO - Handb Exp Pharmacol. 2009;(188):233-49. doi: 10.1007/978-3-540-71029-5_11.